Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Nivagen Pharmaceuticals, Inc. for the product Psoriatar (coal Tar) (NDC 75834-101). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredient, purpose, use, warnings, flammable, do not use, otc - ask doctor, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Coal Tar 2% (from Coal Tar Topical Solution USP, 10%)
Psoriasis
for the relief of symptons of psoriasis
For external use only
Avoid fire, flame, or smoking during and immediately following application.
Ask a doctor before use if you have a condition that covers large areas of the body.
Ask a doctor or pharmacist before use if you are using the product with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs.
When using this product
Stop use and ask doctor if condition worsens or does not improve after regular use of this product as directed.
If pregnant or breast feeding, ask a health professional before use.
Keep out of reach of children.
If swallowed, get medical help or contact a poison control center right away.
Alcohol denatured, caprylic/capric triglyceride, ceteareth-20, cyclopentasiloxane, dimethicone, disodium edta, glycerin, hydroxypropyl methylcellulose, isobutane, isopropyl myristate, mentha piperita (peppermint) oil, phenoxyethanol, polysorbate 80, potassium sorbate, propane, sodium chloride, sodium citrate, stearic acid, water (aqua), xantham gum
1-877-977-0687
* Please review the disclaimer below.